Zydus gets USFDA nod for Omega-3-Acid Ethyl Esters capsules

Omega-3-acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of certain blood fat (triglyceride), the company said in a statement.

New Delhi: Zydus Pharmaceuticals' US arm Nesher Pharmaceuticals Saturday said it has received final approval from the USFDA to market Omega-3-Acid Ethyl Esters Capsules USP (USRLD - Lovaza Capsules).

Omega-3-acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of certain blood fat (triglyceride), the company said in a statement.

Also Read: Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

The group now has 267 approvals and has so far filed over 360 ANDAs (abbreviated new drug applications) since the commencement of the filing process in FY 2003-04.

ANDA is an application for a US generic drug approval for an existing licensed medication or approved drug.

Also Read: Zydus Cadila gets USFDA approval for Esomeprazole Magnesium delayed-release capsules